Integration of somatic mutations in diagnosis and risk assessment in myelodysplastic syndromes (MDS)

被引：0
|
作者：
Della Porta, M. [1 ,2 ]
机构：
[1] Humanitas Res Hosp, Milan, Italy
[2] Humanitas Univ, Milan, Italy
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2017年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O6.01
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [1] RISK ASSESSMENT IN MYELODYSPLASTIC SYNDROMES (MDS)
    Improta, S.
    Gagliardi, A.
    Lucania, A.
    Della Cioppa, P.
    Villa, M. R.
    Esposito, M.
    Quirino, A.
    Mastrullo, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 556 - 557
  • [2] Mutations of myelodysplastic syndromes (MDS): An update
    Ganguly, Bani Bandana
    Kadam, N. N.
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2016, 769 : 47 - 62
  • [3] Incidence of Atrx Mutations in Myelodysplastic Syndromes (MDS)
    Herbaux, Charles
    Duployez, Nicolas
    Badens, Catherine
    Poret, Nicolas
    Gardin, Claude
    Eclache, Virginie
    Daliphard, Sylvie
    Murati, Anne
    Cony-Makhoul, Pascale
    Cheze, Stephane
    Beve, Blandine
    Prebet, Thomas
    Hunault-Berger, Mathilde
    Renneville, Aline
    Figeac, Martin
    Stamatoullas, Aspasia
    Bastard, Christian
    Fenaux, Pierre
    Preudhomme, Claude
    Rose, Christian
    BLOOD, 2014, 124 (21)
  • [4] The Clinical, Cytogenetic and Risk Features of Myelodysplastic Syndromes with no Detectable Somatic Mutations
    Wang, Sa
    Thakral, Beenu
    Morgan, Elizabeth
    Patel, Sanjay
    Nardi, Valentina
    Patel, Keyur
    Weinberg, Olga
    Hasserjian, Robert
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1403 - 1403
  • [5] The Clinical, Cytogenetic and Risk Features of Myelodysplastic Syndromes with no Detectable Somatic Mutations
    Wang, Sa
    Thakral, Beenu
    Morgan, Elizabeth
    Patel, Sanjay
    Nardi, Valentina
    Patel, Keyur
    Weinberg, Olga
    Hasserjian, Robert
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1403 - 1403
  • [6] DIAGNOSIS AND CLINICAL CHARACTERISTICS OF MYELODYSPLASTIC SYNDROMES (MDS)
    KRIEGER, O
    LUTZ, D
    NOWOTNY, H
    HANAK, H
    BLUT, 1983, 47 (03): : 171 - 171
  • [7] Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes
    Itzykson, Raphael
    Kosmider, Olivier
    Fenaux, Pierre
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (04) : 355 - 364
  • [8] TERT Gene Promoter Mutations In Myelodysplastic Syndromes (MDS)
    Matteucci, Caterina
    Iannotti, Tamara
    Brandimarte, Lucia
    Nofrini, Valeria
    Barba, Gianluca
    Sgura, Antonella
    Berardinelli, Francesco
    Nozza, Filomena
    Di Battista, Valeria
    Mecucci, Cristina
    BLOOD, 2013, 122 (21)
  • [9] Treatment of Lower Risk Myelodysplastic Syndromes MDS
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S69 - S70
  • [10] Landscape of Subclonal Mutations in Myelodysplastic Syndromes (MDS) Allows for a Novel Hierarchy of Clonal Advantage By Combining Germline and Somatic Mutations
    Nagata, Yasunobu
    Makishima, Hideki
    Radivoyevitch, Tomas
    Hirsch, Cassandra M.
    Przychodzen, Bartlomiej P.
    Kuzmanovic, Teodora
    Li, Samuel
    Yoshida, Kenichi
    Yoshizato, Tetsuichi
    Adema, Vera
    Negoro, Eiju
    Clemente, Michael J.
    Hosono, Naoko
    Shiraishi, Yuichi
    Chiba, Kenichi
    Tanaka, Hiroko
    Mukherjee, Sudipto
    Nazha, Aziz
    Sole, Francesc
    Carraway, Hetty E.
    Miyano, Satoru
    LaFramboise, Thomas
    Sekeres, Mikkael A.
    Ogawa, Seishi
    Maciejewski, Jaroslaw P.
    BLOOD, 2016, 128 (22)
12345